These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6336666)

  • 1. Should prophylactic antiarrhythmic drug therapy be employed in acute myocardial infarction?
    Berte LE; Harrison DC
    Cardiovasc Clin; 1983; 13(1):173-81. PubMed ID: 6336666
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic lidocaine in acute myocardial infarction: resurface or reburial?
    Yadav AV; Zipes DP
    Am J Cardiol; 2004 Sep; 94(5):606-8. PubMed ID: 15342291
    [No Abstract]   [Full Text] [Related]  

  • 3. The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction.
    Chung EK
    Singapore Med J; 1973 Sep; 14(3):205-10. PubMed ID: 4591400
    [No Abstract]   [Full Text] [Related]  

  • 4. Should prophylactic lidocaine be routinely used in patients suspected of acute myocardial infarction?
    Grauer K
    J Fla Med Assoc; 1982 May; 69(5):377-9. PubMed ID: 7097215
    [No Abstract]   [Full Text] [Related]  

  • 5. Lidocaine prophylaxis against ventricular fibrillation in acute myocardial infarction.
    Ribner HS; Isaacs ES; Frishman WH
    Prog Cardiovasc Dis; 1979; 21(4):287-313. PubMed ID: 368880
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prophylactic use of lidocaine in the acute period of myocardial infarction].
    Fomichev VI; Preobrazhenskiĭ DV
    Klin Med (Mosk); 1995; 73(4):17-20. PubMed ID: 7474809
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative effectiveness of three antiarrhythmic agents in the treatment of ventricular arrhythmias in experimental acute myocardial ischemia.
    Weisse AB; Moschos CB; Passannante AJ; Khan MI; Regan TJ
    Am Heart J; 1971 Apr; 81(4):503-10. PubMed ID: 5552051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiarrhythmic drugs in prevention of recurrent ventricular fibrillation].
    Szmydt W; Brodzińska K; Luczak J
    Pol Tyg Lek; 1971 Jan; 26(3):99-101. PubMed ID: 5545841
    [No Abstract]   [Full Text] [Related]  

  • 9. Routine prophylactic lidocaine in acute myocardial infarction.
    Barnaby PF; Barrett PA; Lvoff R
    Heart Lung; 1983 Jul; 12(4):362-6. PubMed ID: 6553038
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY; Copie X; Iliou MC; Guize L
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():39-42. PubMed ID: 9749275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of the determination of lidocaine and anti-arrhythmic drugs in acute myocardial infarct].
    Matta F; De Marchi M; Pecchio F; Bevilacqua R; Aillon A; Piccinino C; Riva L; Alvino A; Angelino PF
    Minerva Cardioangiol; 1981 Apr; 29(4):131-6. PubMed ID: 7242944
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic lignocaine in hospitalized patients with acute myocardial infarction.
    O'Brien KP; Taylor PM; Croxson RS
    Med J Aust; 1973 Aug; 2(1):Suppl:36-7. PubMed ID: 4598559
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of antiarrhythmics in the post-infarction period].
    Dinanian S
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary ventricular fibrillation: a reason to be cautious.
    Jordaens LJ; T Kindt H
    Eur Heart J; 1997 Jun; 18(6):890-2. PubMed ID: 9183575
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
    Avanzini F; Latini R; Maggioni A; Colombo F; Santoro E; Franzosi MG; Tognoni G
    Arch Intern Med; 1995 May; 155(10):1041-5. PubMed ID: 7748046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary ventricular fibrillation during the acute phase of myocardial infarction (author's transl)].
    Bernard R; Vainsel H; Dereume G; de Hemptinne J; Smets P; Englert M
    Ann Cardiol Angeiol (Paris); 1978 Nov; 27(6):463-5. PubMed ID: 749677
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine.
    Wyman MG; Wyman RM; Cannom DS; Criley JM
    Am J Cardiol; 2004 Sep; 94(5):545-51. PubMed ID: 15342281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic lidocaine use in acute myocardial infarction revisited in the thrombolytic era.
    Tan HL; Lie KI
    Am Heart J; 1999 May; 137(5):770-3. PubMed ID: 10220620
    [No Abstract]   [Full Text] [Related]  

  • 19. Long term survival following myocardial infarction and ventricular fibrillation.
    Duke M
    Conn Med; 1973 Apr; 37(4):180-4. PubMed ID: 4694490
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J; Kerr C; Teo K
    Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.